- Home
- MIO vs AMRN Comparison
MIO vs AMRN Comparison
Compare MIO & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIO
- AMRN
- Stock Information
- Founded
- MIO 2021
- AMRN 1989
- Country
- MIO United States
- AMRN Ireland
- Employees
- MIO N/A
- AMRN N/A
- Industry
- MIO Investment Managers
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MIO Finance
- AMRN Health Care
- Exchange
- MIO Nasdaq
- AMRN Nasdaq
- Market Cap
- MIO 209.0M
- AMRN 236.4M
- IPO Year
- MIO N/A
- AMRN 1993
- Fundamental
- Price
- MIO $12.37
- AMRN $0.53
- Analyst Decision
- MIO
- AMRN Buy
- Analyst Count
- MIO 0
- AMRN 1
- Target Price
- MIO N/A
- AMRN N/A
- AVG Volume (30 Days)
- MIO 46.0K
- AMRN 1.4M
- Earning Date
- MIO 01-01-0001
- AMRN 10-30-2024
- Dividend Yield
- MIO 4.57%
- AMRN N/A
- EPS Growth
- MIO N/A
- AMRN N/A
- EPS
- MIO N/A
- AMRN N/A
- Revenue
- MIO N/A
- AMRN $241,021,000.00
- Revenue This Year
- MIO N/A
- AMRN N/A
- Revenue Next Year
- MIO N/A
- AMRN N/A
- P/E Ratio
- MIO N/A
- AMRN N/A
- Revenue Growth
- MIO N/A
- AMRN N/A
- 52 Week Low
- MIO $9.18
- AMRN $0.46
- 52 Week High
- MIO $11.36
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- MIO 65.53
- AMRN 45.16
- Support Level
- MIO $12.01
- AMRN $0.54
- Resistance Level
- MIO $12.42
- AMRN $0.53
- Average True Range (ATR)
- MIO 0.10
- AMRN 0.03
- MACD
- MIO 0.04
- AMRN 0.00
- Stochastic Oscillator
- MIO 95.16
- AMRN 46.42
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.